Skip to main content
Ortivus logo

Ortivus — Investor Relations & Filings

Ticker · ORTI ISIN · SE0000188930 LEI · 549300AVDV7UC14MTH79 ST Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2023-01-18 M&A Activity
Country SE Sweden
Listing ST ORTI

About Ortivus

https://www.ortivus.com/

Ortivus is a medical technology company that develops and supplies mobile solutions for prehospital and emergency medical care. The company's core product is MobiMed, an advanced electronic Patient Care Record (ePCR) system designed for paramedics and emergency medical services (EMS) providers. MobiMed facilitates real-time documentation and data sharing directly from the field. The platform integrates with a wide range of medical devices, such as patient monitors and defibrillators, as well as with hospital patient administration systems and national health registries. This ensures seamless information flow across the entire care pathway. Key functionalities include structured workflows, automated risk assessments, secure communication, and a web portal for real-time incident overviews. The system also supports telemedicine capabilities, including video consultations. By optimizing documentation and providing actionable insights, Ortivus solutions aim to improve patient safety, enhance care quality, and increase operational efficiency for healthcare organizations.

Recent filings

Filing Released Lang Actions
Ortivus acquires shares in the company H&E Solutions AB
M&A Activity Classification · 99% confidence The document announces that Ortivus has completed the acquisition of shares in H&E Solutions AB, including participation in a new share issue. This involves changes in ownership, capital structure (share issue), and corporate control (receiving a board seat). The text explicitly mentions the EU Market Abuse Regulation and is a formal announcement. While it involves capital changes (CAP) and potential M&A activity (TAR), the core event is a transaction involving the purchase of shares and participation in a share issue. Since the document is a formal announcement detailing a transaction involving the company's own shares (or shares of an entity it is acquiring, which impacts its structure) and a related capital raise, it fits best under Capital/Financing Update (CAP) or potentially Transaction in Own Shares (POS) if Ortivus were buying back its own shares, which it is not. Given the context of acquiring shares and participating in a share issue to strengthen a position, CAP is highly relevant. However, the most specific category for announcements regarding share transactions, especially involving acquisitions or significant ownership changes, often falls under broader transaction/capital categories. Since this is a direct announcement of acquiring shares and participating in a share issue, 'CAP' (Capital/Financing Update) is appropriate, as is 'TAR' (M&A Activity). Given the focus on the share acquisition and the associated share issue, CAP is a strong fit. Alternatively, since it is a formal regulatory announcement that doesn't fit perfectly into the primary financial reports (10-K, IR, ER), it could be RNS. However, the content is highly specific to financing/acquisition. I will classify it as CAP due to the explicit mention of the share issue and investment, which is a financing activity, even though it's framed as an acquisition. The document length is short (4279 chars) and it functions as a press release/regulatory filing announcing the event, not the detailed financial report itself. Since it is a specific announcement, RNS is a fallback, but CAP is more descriptive of the content.
2023-01-18 English
Ortivus kommer nu att leverera MobiMed till Estlands hela ambulansflotta!
Regulatory Filings Classification · 100% confidence The document is a press release written in Swedish announcing a significant contract award for Ortivus to supply its MobiMed ePR system to the entire ambulance fleet in Estonia, in partnership with Telia Eesti. It details the contract value (26 MSEK), duration (5 years), and the nature of the service (SaaS solution for electronic patient records). The concluding statement, "Denna information är sådan information som Ortivus är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning" (This information is information that Ortivus is obliged to disclose pursuant to the EU Market Abuse Regulation), strongly indicates a mandatory regulatory disclosure concerning a major business event. Since this is a specific announcement about a major business development (a large contract win) and not a standard periodic financial report (like 10-K or IR), nor a proxy statement (DEF 14A) or a dividend notice (DIV), it fits best under the general category for regulatory announcements that don't have a more specific code. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a mandatory market disclosure of this nature that isn't covered by other specific codes like CAP (Capital/Financing Update) or TAR (M&A Activity). The document length (5636 chars) is substantial enough that it is the report itself, not just an announcement of a report (RPA).
2022-12-15 Swedish
Ortivus will now deliver MobiMed to Estonia’s entire ambulance fleet!
Regulatory Filings Classification · 100% confidence The document announces a significant business award/contract win by Ortivus (via subcontractor Telia Eesti) with the Estonian Health Insurance Fund for delivering the MobiMed ePR system to the entire ambulance fleet. The text details the contract value (26 MSEK), duration (5 years), and strategic importance. Crucially, the end of the document contains a section titled 'Attachments' with a link to a PDF titled 'Ortivus will now deliver MobiMed to Estonia's entire ambulance fleet!' and a timestamp indicating when the information was submitted for publication under EU Market Abuse Regulation. This structure—a brief announcement detailing a major event followed by a link to the full document—strongly suggests this is an announcement about the publication of information, rather than the full regulatory report itself (like a 10-K or IR). Since it is a general regulatory announcement concerning business operations and not specifically a dividend, director dealing, or capital change, the most appropriate classification is Report Publication Announcement (RPA) or the general Regulatory Filings (RNS). Given the explicit mention of publishing information and providing an attachment link, RPA is the most precise fit, as it signals the release of material news.
2022-12-15 English
Ortivus tecknar Letter of Intent (LoI) med avsikt att förvärva andelar i bolaget H&E Solutions AB
M&A Activity Classification · 99% confidence The document is a press release announcing that Ortivus AB has signed a Letter of Intent (LoI) to acquire shares in H&E Solutions AB, involving a cash investment of 4.0 MSEK as part of a new share issue. The text explicitly mentions that the information is being made public according to the EU Market Abuse Regulation and includes a date and time stamp for public disclosure. This type of announcement, detailing a significant transaction (potential acquisition/investment) and regulatory disclosure, fits best under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS) if it were a general announcement. However, since it details a specific financing/investment activity (participating in a new share issue for an acquisition), 'CAP' is the most precise fit among the specific categories. Given the context of a formal announcement of a transaction, it is not a general RPA or RNS fallback unless no other category applied. It is not an ER, IR, 10-K, or CT. It is a specific corporate action related to capital structure/financing.
2022-12-14 Swedish
Ortivus signs a Letter of Intent (LoI) with the intention of acquiring shares in the company H&E Solutions AB
M&A Activity Classification · 98% confidence The document describes a Letter of Intent (LoI) signed by Ortivus to acquire shares in H&E Solutions AB, specifically mentioning participation in a rights issue. This constitutes an announcement related to a potential merger, acquisition, or significant corporate transaction. This aligns best with the 'M&A Activity' category (TAR). The text also mentions being 'obliged to make public pursuant to the EU Market Abuse Regulation,' suggesting a regulatory disclosure, but the core subject is the acquisition intent, making TAR the most specific fit over the general RNS fallback. The document length is moderate, and it is the primary announcement, not just a notice of publication.
2022-12-14 English
Jersey Ambulance Service har valt Ortivus lösning till sin prehospitala vård
Regulatory Filings Classification · 100% confidence The document announces a new contract win for Ortivus with the Jersey Ambulance Service regarding the delivery of the MobiMed ePR system. It details the order value (3.8 MSEK) and contract length (3 years). Crucially, the final line states: "Denna information är sådan information som Ortivus är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning" (This information is information that Ortivus is obliged to disclose pursuant to the EU Market Abuse Regulation). This strongly indicates a mandatory regulatory disclosure concerning a significant business event, but it is not a standard periodic report (10-K, IR, ER). Since it is a specific, material announcement that doesn't fit the other specific categories (like Director's Dealing, Dividend, or Capital Change), the most appropriate general regulatory filing category is 'Regulatory Filings' (RNS), which serves as the fallback for mandatory, non-standard announcements under EU regulations.
2022-12-06 Swedish

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.